MC1257A1 - Derive pyrrolidinique - Google Patents

Derive pyrrolidinique

Info

Publication number
MC1257A1
MC1257A1 MC791362A MC1362A MC1257A1 MC 1257 A1 MC1257 A1 MC 1257A1 MC 791362 A MC791362 A MC 791362A MC 1362 A MC1362 A MC 1362A MC 1257 A1 MC1257 A1 MC 1257A1
Authority
MC
Monaco
Prior art keywords
pyrrolidinone
methoxybenzoyl
general formula
mixture
hydroxybenzoyl
Prior art date
Application number
MC791362A
Other languages
English (en)
French (fr)
Inventor
W Aschwanden
E Kyburz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1257A1 publication Critical patent/MC1257A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
MC791362A 1978-02-10 1979-02-08 Derive pyrrolidinique MC1257A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH140378 1978-02-10
CH1198178 1978-11-22

Publications (1)

Publication Number Publication Date
MC1257A1 true MC1257A1 (fr) 1980-01-14

Family

ID=25687541

Family Applications (1)

Application Number Title Priority Date Filing Date
MC791362A MC1257A1 (fr) 1978-02-10 1979-02-08 Derive pyrrolidinique

Country Status (34)

Country Link
US (1) US4369139A (cs)
EP (2) EP0044088B1 (cs)
JP (1) JPS6059907B2 (cs)
AR (1) AR220739A1 (cs)
AT (1) AT374787B (cs)
AU (1) AU525514B2 (cs)
BG (1) BG29281A3 (cs)
BR (1) BR7900684A (cs)
CA (1) CA1100515A (cs)
CS (1) CS226182B2 (cs)
CU (1) CU21107A3 (cs)
DD (1) DD141828A5 (cs)
DE (1) DE2963321D1 (cs)
DK (1) DK155278C (cs)
EG (1) EG13873A (cs)
ES (2) ES477587A1 (cs)
FI (1) FI69063C (cs)
GR (1) GR71464B (cs)
HK (1) HK6185A (cs)
HU (1) HU177644B (cs)
IE (1) IE47831B1 (cs)
IL (1) IL56587A0 (cs)
IN (1) IN150106B (cs)
MC (1) MC1257A1 (cs)
MY (1) MY8500340A (cs)
NO (1) NO152046C (cs)
NZ (1) NZ189571A (cs)
OA (1) OA06180A (cs)
PH (1) PH15491A (cs)
PL (1) PL115958B1 (cs)
PT (1) PT69206A (cs)
RO (1) RO76615A (cs)
SU (1) SU931104A3 (cs)
YU (1) YU41330B (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1124247A (en) * 1979-08-09 1982-05-25 Hoffmann-La Roche Limited Pyrrolidine derivatives
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
US4398938A (en) * 1982-05-20 1983-08-16 Velsicol Chemical Corporation N-Acylated lactams and their herbicidal compositions and method of use
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
CH661174GA3 (cs) * 1985-07-10 1987-07-15
US4691853A (en) * 1985-12-30 1987-09-08 Technalytics, Inc. Surgical stapler
US5300642A (en) * 1986-04-10 1994-04-05 The Du Pont Merck Pharmaceutical Company α, α-disubstituted aromatics and heteroaromatics as cognition enhancers
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
US5173489A (en) * 1986-04-10 1992-12-22 The Dupont Merck Pharmaceutical Co. α,α-disubstituted aromatics and heteroaromatics as cognition enhancers
US4876259A (en) * 1987-01-05 1989-10-24 E. I. Du Pont De Nemours And Company 3,3-disubstituted indolines
IT1215587B (it) * 1987-06-26 1990-02-14 Roussel Maestretti Spa Derivati della 1-benzoil2-oxo 5-alcossi pirrolidina, loro procedimento di preparazione e loro impiego come sostanza medicinale.
US5202345A (en) * 1987-08-19 1993-04-13 Shionogi & Co., Ltd. Carbamoylpyrrolidone derivatives and drugs for senile dementia
CA1305148C (en) * 1987-08-19 1992-07-14 Hiromu Matsumura Carbamoylpyrrolidone derivatives and drugs for senile dementia
JP2585086B2 (ja) * 1988-12-28 1997-02-26 大鵬薬品工業株式会社 ジアザビシクロアルカン誘導体
IT1231921B (it) * 1989-06-12 1992-01-15 Sigma Tau Ind Farmaceuti 1-acil-2-pirrolidoni quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
JP2803882B2 (ja) * 1990-02-20 1998-09-24 日清製粉株式会社 １―フエノキシカルボニル―２―ピロリジノン誘導体
JP3038032B2 (ja) * 1991-03-25 2000-05-08 日清製粉株式会社 血小板凝集抑制薬
DE69331761T2 (de) * 1992-07-24 2002-09-12 The Regents Of The University Of California, Oakland Arzneimittel, die den durch ampa rezeptoren vermittelten synaptischen respons erhöhen
US5852008A (en) * 1995-01-24 1998-12-22 The Regents Of The University Of California Heteroatom substituted benzoyl derivatives that enhance synaptic response mediated by receptors
EP0811375B1 (en) * 1995-02-21 2001-01-03 Nippon Suisan Kaisha, Ltd. Glutamic acid receptor agonist
IT1318490B1 (it) * 1999-04-27 2003-08-25 Hoffmann La Roche Agente per fare aumentare la cessione di acetilcolina cerebrale.
KR100823668B1 (ko) 2000-12-28 2008-04-21 해밀턴 파마슈티컬스 인코포레이티드 신경성 통증 치료 및 예방약
US8858594B2 (en) * 2008-12-22 2014-10-14 Abbott Laboratories Curved closure device
EP2604592B1 (en) 2011-12-12 2014-10-08 Zaklady Farmaceutyczne Polpharma SA A process for the purification of aniracetam by crystallisation from aqueous solutions
CN109651222A (zh) * 2018-12-21 2019-04-19 上海昊航化工有限公司 一种阿尼西坦的催化合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697563A (en) * 1970-06-29 1972-10-10 Inst Chemioterapico Italiano S (3,4,5-trimethoxy-benzamido)-alkanoic acids for prophylaxis and treatment of cardiac disorders
DE2413935A1 (de) * 1974-03-20 1975-10-16 Schering Ag 4-(polyalkoxy-phenyl)-2-pyrrolidone

Also Published As

Publication number Publication date
ATA99579A (de) 1983-10-15
AU4391679A (en) 1979-08-16
GR71464B (cs) 1983-05-30
NO152046B (no) 1985-04-15
AT374787B (de) 1984-05-25
YU41330B (en) 1987-02-28
BG29281A3 (bg) 1980-10-15
NO790434L (no) 1979-08-13
IE790246L (en) 1979-08-20
SU931104A3 (ru) 1982-05-23
YU28379A (en) 1983-02-28
JPS54117468A (en) 1979-09-12
EP0044088A3 (en) 1982-02-03
DK155278C (da) 1989-07-24
DK155278B (da) 1989-03-20
EP0044088B1 (de) 1984-02-22
PH15491A (en) 1983-01-31
CU21107A3 (es) 1988-02-01
CS226182B2 (en) 1984-03-19
NZ189571A (en) 1984-07-06
IN150106B (cs) 1982-07-24
AU525514B2 (en) 1982-11-11
DK56379A (da) 1979-08-11
ES477587A1 (es) 1980-01-16
PT69206A (en) 1979-03-01
DE2963321D1 (en) 1982-09-02
EP0005143B1 (de) 1982-07-14
PL213340A1 (cs) 1980-03-24
AR220739A1 (es) 1980-11-28
IE47831B1 (en) 1984-06-27
PL115958B1 (en) 1981-05-30
JPS6059907B2 (ja) 1985-12-27
FI69063C (fi) 1985-12-10
MY8500340A (en) 1985-12-31
IL56587A0 (en) 1979-05-31
US4369139A (en) 1983-01-18
EG13873A (en) 1982-12-31
EP0044088A2 (de) 1982-01-20
OA06180A (fr) 1981-06-30
ES483756A1 (es) 1980-04-16
FI69063B (fi) 1985-08-30
HU177644B (en) 1981-11-28
CA1100515A (en) 1981-05-05
BR7900684A (pt) 1979-09-04
EP0005143A1 (de) 1979-11-14
HK6185A (en) 1985-02-01
NO152046C (no) 1985-07-24
FI790226A7 (fi) 1979-08-11
DD141828A5 (de) 1980-05-21
RO76615A (ro) 1981-04-30

Similar Documents

Publication Publication Date Title
FI69063B (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbart 1-(p-metoxibensoyl)-2-pyrrolidinon samt i detta som mellanprodukter anvaendbara 1-(p-hydroxibensoyl)-2-pyrrolidinon 4-(p-metoxibensoylamino)smoersyra och 2-pyrrolinonderivat
EP0165919B1 (fr) (R)-alpha-éthyl-2-oxo-1-pyrrolidineacétamide
EP0005689B1 (fr) Nouveaux acides lactame-N-acétiques et leurs amides, leurs procédés de préparation et compositions thérapeutiques
EP0734379B1 (fr) Derives de 2-arylalkenyl-azacycloalkanes ligands aux recepteurs sigma, leur procede de preparation et leur application en therapeutique
EP0229566B1 (fr) Dérivés de la 1-benzène sulfonyl 2-oxo 5-alcoxy pyrrolidine, leur procédé de préparation, leur application comme médicaments et les compositions les renfermant
FR2548666A1 (fr) Nouveaux derives du nor-tropane et du granatane, leur procede de preparation et leur application en therapeutique
FR2546166A1 (fr) Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique
BE1008622A3 (fr) Derives de l'epi-epibatidine.
CH625214A5 (cs)
EP0024030B1 (de) Pyrrolidin-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
EP0443918A1 (fr) Nouveaux dérivés de la 20,21-dinoréburnaménine, leur procédé de préparation et les nouveaux intermédiaires ainsi obtenus, leur application comme médicaments et les compositions les renfermant
DE69400702T2 (de) N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
CH632999A5 (fr) (2-thio)urees 1,3-disubstituees.
JPH0128019B2 (cs)
EP0300850B1 (fr) Dérivés de 1-arylsulfonyl 1,5-dihydro 2H-pyrrol-2-one, leurs procédé et intermédiaires de préparation, leur application comme médicaments et les compositions les renfermant
EP0239500B1 (fr) Dérivés de la 1-styrène sulfonyl 2-oxo 5-hydroxy pyrrolidine, leur procédé et des intermédiaires de préparation, leur application comme médicaments et les compositions les renfermant
EP0294295B1 (fr) Dérivés de la 1-arylsulfonyl 2-oxo 5-alcoxy pyrrolidine, leur procédé de préparation, leur application comme médicaments et les compositions les renfermant
DE3874030T2 (de) 1-benzensulfonyl-2-oxo 5-alkylthio pyrrolidin-derivate, verfahren zur herstellung und zwischenprodukte und verwendung als heilmittel.
FR2522663A1 (fr) Nouveaux alcaloides ergopeptidiques, leur preparation et leur utilisation comme medicaments
EP0001585A1 (de) Piperazino-pyrrolobenzodiazepine, Verfahren zu ihrer Herstellung sowie pharmazeutische Präparate enthaltend diese Verbindungen
EP0054593B1 (fr) Dérivés du pyrrole protecteurs du myocarde ayant une activité antiarythmique et antiagrégante plaquettaire, leur procédé de préparation et les médicaments en contenant
EP0490765A2 (fr) Dérivés de la 1-arylsulfonyl 2-pyrrolidone, leur procédé de préparation et les nouveaux intermédiaires obtenus, leur application comme médicaments et les compositions pharmaceutiques les renfermant
EP0352575A2 (de) Substituierte anellierte Pyrrole
FR2492374A1 (fr) Derives du pyrrole protecteurs du myocarde ayant une activite antiarythmique et antiplaquettaire, leur procede de preparation et les medicaments en contenant
Peet THE SYNTHESIS OF KETODIAZOPEPTIDES AND THEIR REDUCTION TO THREONYLGLYCINEDERIVATIVES; PREPARATION OF 1, 2, 3-THIADIAZOLES

Legal Events

Date Code Title Description
YP Annual fee paid
YP Annual fee paid